- Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi‑center prospective investigation (PI: Xiang Shu)
- Genomic analyses using whole exome sequencing in a subset of the WECARE study population (PIs: Bernstein, Buas)
- Cognitive aging in long‑term breast cancer survivors (PI: Root)
- Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer’s Disease and Related Dementias (PI: Ahles; Carroll, J, UCLA)
- Multi‑Ancestry Mapping of Pancreatic Cancer Susceptibility Loci (PI: Margaret Du)
- MSK Pancreatic Cancer Screening & Monitoring Program/ Pancreatic Tumor Registry (PIs: Du & Rolston)
- Genetic susceptibility to Barrett’s esophagus: From GWAS to biology (PI: Buas)
- Identification of Lethal Melanomas at the Time of Diagnosis (PIs: Begg; Thomas, UNC; Berwick, UNM)
- Elucidating non-invasive markers of early-stage melanocytic evolution to minimize over-diagnosis (PI: Sahu)
- Extended Primary Melanomas Pathology Review (an InterMEL Study)
- Integration of Clinical and Molecular Biomarkers for Melanoma Survival (InterMEL)
- Allostatic load and cognition in older breast cancer survivors
- Personalized genomic testing for melanoma: maximizing comprehension and health outcomes in skin cancer patients
- Effect and mechanism of acupuncture for cancer-related cognitive difficulties
- Participation in Consortia: International Lung Cancer Consortium (ILCCO); Ovarian Cancer Consortium (OCAC); Pancreatic cancer consortia (Panc4; PanScan)
- Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
- Multi‑Ancestry Mapping of Pancreatic Cancer Susceptibility Loci
- Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
- Effect and Mechanism of Acupuncture for Cancer‑related Cognitive Impairment (ENHANCE)